# Eli Lilly launches new weight loss pill Foundayo in U.S.

*business · news · 2026-04-09 · Seeking Alpha*

## Key points

- Eli Lilly has launched its new weight loss pill Foundayo in U.S. retail pharmacies.
- Foundayo's active ingredient is orforglipron, which was recently approved for use.
- This launch positions Eli Lilly in direct competition with Novo Nordisk's Wegovy.
- Foundayo is now immediately available nationwide, marking a significant market entry.

**Companies:** Eli Lilly and Company, Novo Nordisk
**Countries:** United States

[Read the full story on Seeking Alpha](https://seekingalpha.com/news/4573674-eli-lilly-launches-new-weight-loss-pill-foundayo)

---

Canonical: https://newsio.io/n/eaf0e762-6dec-41e1-8382-d7c2c0d09a8c/eli-lilly-launches-new-weight-loss-pill-foundayo-in-u-s
Summarized by Newsio from Seeking Alpha. https://newsio.io/how-it-works